Trial Profile
A randomized, open-label, single dose, 2 cohort, 2 period crossover trial to evaluate the effect of food on the pharmacokinetics of emtricitabine/rilpivirine/tenofovir-alafenamide single tablet regimen under fasted and fed conditions in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 04 Mar 2016 New trial record